US health agency has sent drug pricing pilot to the White House

NEW YORK (Reuters) -The U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services on Thursday sent the White House the details of a drug pricing pilot for official review, according to a government website. The pilot, titled Global Benchmark for Efficient Drug Pricing (GLOBE) Model, will need to be cleared by the White House's Office of Management and Budget